DP
KITE

DSAM Partners’s Kite Pharma, Inc. KITE Stock Holding History

DSAM Partners’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,864
Closed -$515K – 72
2017
Q3 		$515K Sell
2,864
-90,106
-97% -$12.6M 0.07% 47
2017
Q2 		$9.64M Sell
92,970
-3,990
-4% -$326K 1.71% 21
2017
Q1 		$7.61M Buy
96,960
+7,458
+8% +$461K 1.66% 20
2016
Q4 		$4.01M Sell
89,502
-128,810
-59% -$6.32M 1.11% 18
2016
Q3 		$12.2M Sell
218,312
-13,073
-6% -$728K 2.67% 18
2016
Q2 		$11.6M Sell
231,385
-25,165
-10% -$1.24M 3.53% 15
2016
Q1 		$11.8M Sell
256,550
-56,387
-18% -$2.73M 5.26% 8
2015
Q4 		$19.3M Buy
312,937
+47,297
+18% +$3.33M 4.94% 7
2015
Q3 		$14.8K Sell
265,640
-76,548
-22% -$4.81M 4.38% 8
2015
Q2 		$20.9K Buy
342,188
+8,375
+3% +$478K 3.79% 7
2015
Q1 		$19.3K Sell
333,813
-65,758
-16% -$4.41M 4.71% 4
2014
Q4 		$23K Sell
399,571
-47,666
-11% -$2.01M 6.08% 4
2014
Q3 		$12.7K Buy
+447,237
New +$11.1M 0.04% 9

DSAM Partners's KITE Position: Q4 2017 in Review

DSAM Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 2,864 shares — an estimated $515K sold.

DSAM Partners first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $19.3M in Q4 2015. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • DSAM Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • DSAM Partners sold 2,864 Kite Pharma, Inc. shares in Q4 2017, an estimated $515K.
  • DSAM Partners first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
  • DSAM Partners's Kite Pharma, Inc. position peaked at $19.3M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on DSAM Partners's 13F filing for Q4 2017, filed 5 Feb 2018.